- Trials with a EudraCT protocol (44,349)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44,349 result(s) found.
Displaying page 446 of 2,218.
EudraCT Number: 2006-003684-32 | Sponsor Protocol Number: ISTANT | Start Date*: 2008-06-18 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: Integrilin plus stenting to avoid myocardial necrosis trial. Pilot Study | |||||||||||||
Medical condition: patients with diffuse CAD undergoing percutaneous treatment on a native coronary vassel with planned implantation of 33 mm of DES with reference vessel diameter 2.25-4.0 mm. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002787-95 | Sponsor Protocol Number: WP-07-148 | Start Date*: 2008-01-03 | |||||||||||
Sponsor Name:Department of Pulmonology, Rijnstate Hospital | |||||||||||||
Full Title: A randomized double-blind study of N-Acetylcysteine vs. placebo to Prevent Neurotoxicity induced by Platinum containing chemotherapy in patients treated for (Non)Small Cell Lung Cancer and Malignan... | |||||||||||||
Medical condition: Cisplatin-induced peripheral neuropathy will be investigated. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002791-33 | Sponsor Protocol Number: 2007-17 | Start Date*: 2008-04-16 |
Sponsor Name:Assistance Publique Hopitaux de marseille | ||
Full Title: Effet aigu d’une insulinothérapie intensive sur le métabolisme des lipoparticules riches en triglycérides (LRT) intestinales chez le patient diabétique de type 2 | ||
Medical condition: DIABETIQUE DE TYPE II | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002663-11 | Sponsor Protocol Number: PSD506-OAB-002 | Start Date*: 2006-10-17 | |||||||||||
Sponsor Name:Plethora Solutions Limited | |||||||||||||
Full Title: An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects wit... | |||||||||||||
Medical condition: Unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002670-22 | Sponsor Protocol Number: P04807 | Start Date*: 2007-10-31 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a division of Schering Corporation | |||||||||||||
Full Title: Comparison of the Efficacy and Safety of Infliximab, as Monotherapy or in Combination With Azathioprine, Versus Azathioprine Monotherapy in Moderate to Severe Active Ulcerative Colitis (Part 1). C... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Prematurely Ended) BE (Completed) HU (Prematurely Ended) CZ (Completed) PT (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) IT (Prematurely Ended) SK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005063-29 | Sponsor Protocol Number: GEMOXA001 | Start Date*: 2006-01-01 | |||||||||||
Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI | |||||||||||||
Full Title: Induction Chemotherapy with Gemcitabine-Oxaliplatin GEM-OXA followed by concomitant weekly Gemcitabine plus Radiotherapy GEM/RT in Locally Advanced, Unresectable Pancreatic Cancer A Phase II ... | |||||||||||||
Medical condition: Locally advanced pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005066-37 | Sponsor Protocol Number: AC-052-415 | Start Date*: 2006-03-15 |
Sponsor Name:Actelion Pharmaceuticals Ltd. | ||
Full Title: COMPASS-1 / Hemodynamic effects of a single dose of sildenafil in symptomatic patients on bosentan treatment for pulmonary arterial hypertension – A multicenter, open-label, non-comparative, prospe... | ||
Medical condition: Symptomatic Pulmonary Arterial Hypertension (WHO functional class II-III) of the following types: - Idiopathic - Familial - Associated with: Corrected congenital s... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) IT (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002203-17 | Sponsor Protocol Number: TETRIZ | Start Date*: 2005-09-02 |
Sponsor Name:Fundació de Lluita Contra la Sida | ||
Full Title: Estudio piloto unicéntrico, abierto, aleatorizado para evaluar la evolución inmuno-virológica y clínica de una combinación con análogos a nucleósidos/nucléotidos (TrizivirÒ +Tenofovir) en pacientes... | ||
Medical condition: Pacientes con infección por VIH | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002958-21 | Sponsor Protocol Number: HOE901/4059 | Start Date*: 2005-09-21 |
Sponsor Name:Sanofi-Synthelabo Rt. | ||
Full Title: The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic d... | ||
Medical condition: Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-002965-35 | Sponsor Protocol Number: GID18 | Start Date*: 2005-09-15 | |||||||||||
Sponsor Name:Sanofi Pasteur SA | |||||||||||||
Full Title: Safety of the Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Healthy Children | |||||||||||||
Medical condition: Vaccination of healthy children aged 6 to 35 months and 3 to 8 years (2 doses at a 28 day-interval) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002978-30 | Sponsor Protocol Number: KG2104940 | Start Date*: 2005-11-28 | |||||||||||
Sponsor Name:GlaxoSmithKlin Research and Development Ltd | |||||||||||||
Full Title: A double-blind, randomized, placebo-controlled, repeat dose study to compare the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK189075 with GW869682 in subjects with type 2 diabe... | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001033-15 | Sponsor Protocol Number: NK-104-302 | Start Date*: 2005-08-01 | |||||||||||
Sponsor Name:Kowa Research Europe Ltd. | |||||||||||||
Full Title: STUDY OF PITAVASTATIN 2 MG vs. SIMVASTATIN 20 MG AND PITAVASTATIN 4 MG vs. SIMVASTATIN 40 MG (FOLLOWING UP-TITRATION) IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA | |||||||||||||
Medical condition: PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001041-42 | Sponsor Protocol Number: VAC030 | Start Date*: 2005-05-23 |
Sponsor Name:University of Oxford | ||
Full Title: Assessment of protection against malaria by sporozoite challenge of healthy adults vaccinated with the virosomal vaccine PEV3A and FP9-MVA ME-TRAP | ||
Medical condition: Plasmodium falciparum malaria | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005857-23 | Sponsor Protocol Number: MC/PR/033011/003/05 | Start Date*: 2006-05-08 | |||||||||||
Sponsor Name:CHIESI | |||||||||||||
Full Title: DOUBLE BLIND, DOUBLE DUMMY, RANDOMISED, PARALLEL GROUP, MONOCENTRIC CLINICAL TRIAL ON THE EFFECTS OF CHF 1535 MDI OR SERETIDE DPI ON LUNG HYPERINFLATION AND EXERCISE TOLERANCE IN PATIENTS WITH COPD... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005863-26 | Sponsor Protocol Number: TAK-583/EC201 | Start Date*: 2006-09-22 | |||||||||||
Sponsor Name:Takeda Global Research & Development Centre (Europe) Ltd | |||||||||||||
Full Title: A Phase II, double blind, placebo controlled, dose-ranging study in patients with post herpetic neuralgia (PHN) to evaluate the efficacy, safety, tolerability and pharmacokinetics of four doses of ... | |||||||||||||
Medical condition: Postherpetic neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) NL (Completed) DE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005905-51 | Sponsor Protocol Number: W0003-01 | Start Date*: 2006-02-20 |
Sponsor Name:Stiefel Laboratories (Maidenhead) Limited trading as Stiefel International Research and Development | ||
Full Title: A PHASE II, SINGLE CENTRE, RANDOMISED, PARALLEL GROUP, CLINICAL STUDY TO INVESTIGATE THE TOLERABILITY OF DOUBLE BLIND CICLOPIROX NAIL PRODUCT COMPARED TO DOUBLE BLIND PLACEBO NAIL PRODUCT COMPARED ... | ||
Medical condition: Mild to moderate onychomycosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IS (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000584-13 | Sponsor Protocol Number: ASSENTE | Start Date*: 2007-05-15 | |||||||||||
Sponsor Name:OSPEDALE MAGGIORE DI MILANO (IRCCS) | |||||||||||||
Full Title: Normothermia in patients with acute cerebral damage | |||||||||||||
Medical condition: Subarachnoid hemorrhage, traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000858-45 | Sponsor Protocol Number: S308.3.006 | Start Date*: 2006-12-18 |
Sponsor Name:Solvay Pharmaceuticals | ||
Full Title: An open label SLV308 safety extension to study S308.3.001 in early PD patients. | ||
Medical condition: Parkinson's Disease Early Stage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) SK (Completed) SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000874-56 | Sponsor Protocol Number: BAY12-8039/11976 | Start Date*: 2006-06-12 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A prospective, randomized, double dummy, double blind, multi-center trial comparing the safety and efficacy of moxifloxacin 400 mg IV QD 24 hours to that of ertapenem 1.0 g IV QD 24 hours for 5 to ... | |||||||||||||
Medical condition: Complicated intra-abdominal Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) BE (Completed) EE (Completed) DE (Completed) ES (Completed) LV (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006315-68 | Sponsor Protocol Number: B3D-EW-GHDH | Start Date*: 2007-05-07 |
Sponsor Name:Eli Lilly and Company Limited | ||
Full Title: Comparison of the Effects of Teriparatide with those of Risendronate on Lumbar Spine Volumetric Bone Mineral Density in GLucocorticpid-Induced Osteoporosis in Men | ||
Medical condition: Males with glucocorticoid-induced osteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DE (Completed) GR (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
